Smarter leaders trust GlobalData

Data Insights Innovation in medical: cardiac stimulation implants

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

Johnson & Johnson

Abbott Laboratories

Medtronic Plc

Asahi Kasei Corp

Toray Industries Inc

View all

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilizing and reaching maturity.

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.

35+ innovations will shape the medical devices industry

According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 165,000 patents, there are 35+ innovation areas that will shape the future of the industry.

Within the emerging innovation stage, ultrasonic nebulizers and intra-oral 3D imaging are disruptive technologies that are in the early stages of application and should be tracked closely. Automated diabetes management, cardiac stimulation implants, and transdermal drug delivery are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas is CPR assistance devices and fall detection monitoring, which is now well established in the industry.

Innovation S-curve for the medical devices industry

Cardiac stimulation implants is a key innovation area in medical devices

Cardiac stimulation implants are medical devices that use electrical signals to regulate the heart's rhythm and treat conditions such as bradycardia, heart failure, and arrhythmias. These implants are typically inserted through surgery and consist of two parts: a pulse generator and one or more leads that connect to the heart. The pulse generator sends electrical signals through the leads to regulate the heart's rhythm and can also collect and transmit data to healthcare professionals for monitoring and adjustments.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 420+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of cardiac stimulation implants.

Key players in cardiac stimulation implants – a disruptive innovation in the medical devices industry

‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.   

‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.  

Patent volumes related to cardiac stimulation implants

Asahi Kasei is one of the leading patent filers in the field of cardiac stimulation implants. Some other key patent filers in the field include Medtronic, Boston Scientific, and Abbott Laboratories.

In terms of application diversity, Johnson & Johnson leads the pack, while Ecole Polytechnique Federale de Lausanne, and Alphabet stood in the second and third positions, respectively. By means of geographic reach, Toray Industries held the top position, followed by Tivic Health Systems and Man & Science.

The landscape of cardiac procedures is being reshaped by cardiac stimulation implants, as they undergo a transformation towards greater compactness, thereby boosting their efficiency. The downsizing promises to simplify implantation procedures, with the potential to reduce complications. Moreover, the integration of wireless connectivity in these cardiac implants is anticipated, enabling remote monitoring and programming. This advancement empowers both patients and healthcare providers to access real-time information regarding the device's performance and the patient's cardiac health, fostering more individualized care and prompt interventions. These innovative implants can be customized through artificial intelligence (AI) integration, resulting in enhanced treatment plans.

To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.